Tag Archives: CTC

Biocept Awarded U.S. Patent with Broad Claims for Antibody Capture of Targets of Interest on Any Solid Surface Including CTCs and Exosomes Shed by Solid Tumors into Blood


Company’s intellectual property portfolio now features 20 issued patents protecting its proprietary liquid biopsy platform technology Biocept, Inc. a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer ...

Read More »